Terms: = Testicular cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Treatment
5 results:
1. Therapy-related myelodysplasia and acute myeloid leukemia.
Bhatia S
Semin Oncol; 2013 Dec; 40(6):666-75. PubMed ID: 24331189
[TBL] [Abstract] [Full Text] [Related]
2. [A case of therapy-related leukemia/myelodysplastic syndrome following treatment of refractory testicular germ cell tumor].
Takizawa A; Miura T; Fujinami K; Osada Y; Tanaka M; Maruta I
Nihon Hinyokika Gakkai Zasshi; 2005 Nov; 96(7):701-4. PubMed ID: 16363657
[TBL] [Abstract] [Full Text] [Related]
3. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.
Kollmannsberger C; Hartmann JT; Kanz L; Bokemeyer C
J Cancer Res Clin Oncol; 1998; 124(3-4):207-14. PubMed ID: 9619748
[TBL] [Abstract] [Full Text] [Related]
4. Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment.
van Leeuwen FE
Baillieres Clin Haematol; 1996 Mar; 9(1):57-85. PubMed ID: 8730551
[TBL] [Abstract] [Full Text] [Related]
5. Involvement of 11p15 and 3q21q26 in therapy-related myeloid leukemia (t-ML) in children. Case reports and review of the literature.
Stark B; Jeison M; Shohat M; Goshen Y; Vogel R; Cohen IJ; Yaniv I; Kaplinsky C; Zaizov R
Cancer Genet Cytogenet; 1994 Jul; 75(1):11-22. PubMed ID: 8039158
[TBL] [Abstract] [Full Text] [Related]
